Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements.

Yarom N, Hovan A, Bossi P, Ariyawardana A, Jensen SB, Gobbo M, Saca-Hazboun H, Kandwal A, Majorana A, Ottaviani G, Pentenero M, Nasr NM, Rouleau T, Lucas AS, Treister NS, Zur E, Ranna V, Vaddi A, Cheng KKF, Barasch A, Lalla RV, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2019 Oct;27(10):3997-4010. doi: 10.1007/s00520-019-04887-x. Epub 2019 Jul 8.

PMID:
31286229
2.

Phase retrieval for arbitrary Fresnel-like linear shift-invariant imaging systems suitable for tomography.

Hrivňak S, Hovan A, Uličný J, Vagovič P.

Biomed Opt Express. 2018 Aug 21;9(9):4390-4400. doi: 10.1364/BOE.9.004390. eCollection 2018 Sep 1.

3.

Phosphorescence Kinetics of Singlet Oxygen Produced by Photosensitization in Spherical Nanoparticles. Part I. Theory.

Hovan A, Datta S, Kruglik SG, Jancura D, Miskovsky P, Bánó G.

J Phys Chem B. 2018 May 24;122(20):5147-5153. doi: 10.1021/acs.jpcb.8b00658. Epub 2018 May 14.

PMID:
29709188
4.

Phosphorescence Kinetics of Singlet Oxygen Produced by Photosensitization in Spherical Nanoparticles. Part II. The Case of Hypericin-Loaded Low-Density Lipoprotein Particles.

Datta S, Hovan A, Jutková A, Kruglik SG, Jancura D, Miskovsky P, Bánó G.

J Phys Chem B. 2018 May 24;122(20):5154-5160. doi: 10.1021/acs.jpcb.8b00659. Epub 2018 May 14.

PMID:
29709185
5.

Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study.

Brennan MT, Hasséus B, Hovan AJ, Raber-Durlacher JE, Blijlevens NM, Huysmans MC, Garming Legert K, Johansson JE, Moore CG, von Bültzingslöwen I.

JMIR Res Protoc. 2018 Apr 23;7(4):e103. doi: 10.2196/resprot.8982.

6.

Salivary flow rate after conventional and intensity-modulated radiation therapy.

Nguyen CT, Lin S, Clark H, Hovan A, Wu J.

J Am Dent Assoc. 2018 Jun;149(6):432-441. doi: 10.1016/j.adaj.2018.01.031. Epub 2018 Apr 11.

PMID:
29655708
7.

Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer.

Thor M, Owosho AA, Clark HD, Oh JH, Riaz N, Hovan A, Tsai J, Thomas SD, Yom SHK, Wu JS, Huryn JM, Moiseenko V, Lee NY, Estilo CL, Deasy JO.

Radiother Oncol. 2017 Feb;122(2):200-206. doi: 10.1016/j.radonc.2016.11.005. Epub 2016 Nov 24.

8.

Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.

van Luijk P, Pringle S, Deasy JO, Moiseenko VV, Faber H, Hovan A, Baanstra M, van der Laan HP, Kierkels RG, van der Schaaf A, Witjes MJ, Schippers JM, Brandenburg S, Langendijk JA, Wu J, Coppes RP.

Sci Transl Med. 2015 Sep 16;7(305):305ra147. doi: 10.1126/scitranslmed.aac4441.

9.

Regional radiation dose susceptibility within the parotid gland: effects on salivary loss and recovery.

Clark H, Hovan A, Moiseenko V, Thomas S, Wu J, Reinsberg S.

Med Phys. 2015 Apr;42(4):2064-71. doi: 10.1118/1.4915077.

PMID:
25832096
10.

A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis.

Hawley P, Hovan A, McGahan CE, Saunders D.

Support Care Cancer. 2014 Mar;22(3):751-61. doi: 10.1007/s00520-013-2031-0. Epub 2013 Nov 13.

PMID:
24221577
11.

Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients.

Jensen SB, Jarvis V, Zadik Y, Barasch A, Ariyawardana A, Hovan A, Yarom N, Lalla RV, Bowen J, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3223-32. doi: 10.1007/s00520-013-1884-6. Epub 2013 Jul 31. Review.

PMID:
23900593
12.

Systematic review of natural agents for the management of oral mucositis in cancer patients.

Yarom N, Ariyawardana A, Hovan A, Barasch A, Jarvis V, Jensen SB, Zadik Y, Elad S, Bowen J, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3209-21. doi: 10.1007/s00520-013-1869-5. Epub 2013 Jun 14. Review.

PMID:
23764678
13.

Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset.

Moiseenko V, Wu J, Hovan A, Saleh Z, Apte A, Deasy JO, Harrow S, Rabuka C, Muggli A, Thompson A.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1108-14. doi: 10.1016/j.ijrobp.2011.04.020. Epub 2011 Jun 2.

14.

Response to letter to the editor titled: A matter of taste: making the distinction between taste and flavor is essential for improving management of dysgeusia.

Hovan AJ.

Support Care Cancer. 2011 May;19(5):729. doi: 10.1007/s00520-011-1108-x. Epub 2011 Feb 24. No abstract available.

PMID:
21347524
15.

A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea.

Elad S, Zadik Y, Hewson I, Hovan A, Correa ME, Logan R, Elting LS, Spijkervet FK, Brennan MT; Viral Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO).

Support Care Cancer. 2010 Aug;18(8):993-1006. doi: 10.1007/s00520-010-0900-3. Epub 2010 Jun 11. Review.

PMID:
20544224
16.

Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.

Peterson DE, Doerr W, Hovan A, Pinto A, Saunders D, Elting LS, Spijkervet FK, Brennan MT.

Support Care Cancer. 2010 Aug;18(8):1089-98. doi: 10.1007/s00520-010-0898-6. Epub 2010 Jun 6. Review.

PMID:
20526784
17.

A systematic review of dysgeusia induced by cancer therapies.

Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, Elting LS, Spijkervet FK, Brennan MT; Dysgeusia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO).

Support Care Cancer. 2010 Aug;18(8):1081-7. doi: 10.1007/s00520-010-0902-1. Epub 2010 May 22. Review.

PMID:
20495984
18.

Management of Frey syndrome using botulinum neurotoxin: a case report.

Ng S, Torjek C, Hovan A.

J Can Dent Assoc. 2009 Nov;75(9):651-4.

19.

What do I say to my patient who needs a biopsy?

Hovan AJ, Laronde DM, Zhang L, Currie BL.

J Can Dent Assoc. 2008 Apr;74(3):257-8. No abstract available.

PMID:
18389926
20.

Evaluation of a suspicious oral mucosal lesion.

Williams PM, Poh CF, Hovan AJ, Ng S, Rosin MP.

J Can Dent Assoc. 2008 Apr;74(3):275-80.

21.

Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome.

Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, Nakamura H, Berean K, Hovan A, Le ND, Hislop G, Priddy R, Hay J, Lam WL, Rosin MP.

Cancer Res. 2005 Sep 1;65(17):8017-21.

22.

Oral candidiasis in HIV-infected patients.

Brawner DL, Hovan AJ.

Curr Top Med Mycol. 1995;6:113-25. Review. No abstract available.

PMID:
8724244

Supplemental Content

Support Center